Stem cell program wins key court ruling, poised to issue grants
By San Francisco Chronicle,
San Francisco Chronicle
| 11. 30. 2005
California's embattled Proposition 71 stem cell program took a big step Tuesday toward overcoming lawsuits that have blocked its first grants from being issued.
Alameda County Superior Court Judge Bonnie Sabraw denied essentially every legal argument brought by the plaintiffs in litigation alleging that Prop. 71 violated the state Constitution because it would allow taxpayer-backed bond revenues to be distributed without direct legislative control.
The Prop. 71 program was created by state voters in November 2004 with authority to disperse $3 billion in grants during the next 10 years, mostly intended to advance controversial embryonic stem cell research. A state agency called the California Institute for Regenerative Medicine has been created and based in San Francisco.
Lawsuits challenging the institute's plans were filed by taxpayer groups and an anti-abortion bioethics organization, frustrating research advocates who say stem cells are key to creating a radical new kind of cell-based medicine that is potentially capable of curing such maladies as Parkinson's disease, diabetes and spinal cord injuries.
Now, the program's leadership hopes to move forward by January with a stopgap funding plan...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...